6:49 PM
Oct 23, 2015
 |  BC Extra  |  Politics & Policy

PFMD outlines priorities, invites payers and regulators

The Patient Focused Medicines Development initiative outlined its priorities and invited other stakeholders including payers and regulators to join.

PFMD is a public-private partnership between industry and patient groups that was launched in May. Founding members include Amgen Inc. (NASDAQ:AMGN), AstraZeneca plc (LSE:AZN; NYSE:AZN), UCB Group (Euronext:UCB),...

Read the full 234 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >